Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT03039439
Status
Recruiting
Apply to this trial

Conditions

  • Parathyroid Gland Adenoma
  • Parathyroid Gland Atypical Adenoma
  • Parathyroid Gland Carcinoma
  • Primary Hyperparathyroidism

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Previously collected tumor tissue and blood samples
  • Laboratory Biomarker Analysis — OTHER
    Correlative studies

Study Details

This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profiling of tumors may help doctors avoid inconsistencies in diagnosis, unnecessary or incomplete surgery, surgical morbidity, psychological stress, and inadequate follow up.

Key Dates

Start date
Nov 24, 2015
Status verified
May 2026
Primary completion
Nov 30, 2028
Completion
Nov 30, 2028

Study Design

Enrollment
310 participants (estimated)

Arms

  • Arm: Ancillary-Correlative (laboratory biomarker analysis)
    Previously collected tumor tissue and blood samples are analyzed via immunohistochemical profiling for identifying potential genes showing molecular aberrations as other types of cancer.

Primary Outcome Measure

Biomarker levels [ Time Frame: Up to 4 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Nancy Perrier
713-745-2168
Nancy Perrier (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies